Sintilimab Combined With Chemotherapy for Adjuvant Treatment of Mucosal Melanoma After Surgery
Clinical trial NCT07400302 · RECRUITING
Trial details
- NCT number
- NCT07400302
- Sponsor
- The First Hospital of Jilin University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-02-01
- Primary completion
- 2029-09-30
- Enrollment
- 220
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.